Agape ATP Corporation (NASDAQ:ATPC - Get Free Report) was the recipient of a large decline in short interest in the month of August. As of August 31st, there was short interest totaling 3,500 shares, a decline of 93.5% from the August 15th total of 54,000 shares. Based on an average daily trading volume, of 46,200 shares, the short-interest ratio is currently 0.1 days. Approximately 0.0% of the company's stock are short sold. Approximately 0.0% of the company's stock are short sold. Based on an average daily trading volume, of 46,200 shares, the short-interest ratio is currently 0.1 days.
Agape ATP Stock Up 0.8%
Shares of ATPC traded up $0.01 during midday trading on Thursday, hitting $1.34. The company had a trading volume of 256 shares, compared to its average volume of 1,307,495. The company's 50 day moving average price is $1.34 and its 200 day moving average price is $1.47. The stock has a market cap of $67.01 million, a price-to-earnings ratio of -3.27 and a beta of -0.98. Agape ATP has a 52 week low of $0.90 and a 52 week high of $2.95.
Agape ATP (NASDAQ:ATPC - Get Free Report) last released its earnings results on Wednesday, August 13th. The company reported ($0.01) earnings per share for the quarter. Agape ATP had a negative return on equity of 20.32% and a negative net margin of 183.13%.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen raised shares of Agape ATP from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd.
View Our Latest Research Report on ATPC
About Agape ATP
(
Get Free Report)
Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agape ATP, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agape ATP wasn't on the list.
While Agape ATP currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.